Ingredient

Yeast Beta-Glucan

Ingredient information and published studies.

Find products
Share

Email article

Published

Yeast beta-glucan is a carbohydrate from the cell walls of the yeast Saccharomyces cerevisiae, used for baking or brewing. Its glucose chain has beta-1,3 links, with side branches attached by beta-1,6 links. It is a different molecule from the beta-glucan of oats and barley. Supplements list it as an ingredient, sometimes under brand names such as Wellmune or Yestimun.

Terms and sources
beta-1,3 links
The numbers say which carbon atoms of two glucose units are joined. Stier et al., Nutrition Journal, 2014.

Yeast beta-glucan in the body

Beta-glucans are chains of glucose found in bacteria, fungi including yeast, algae and plants. In yeast beta-glucan, the main chain has beta-1,3 links, and side branches hang on beta-1,6 links. Oat and barley beta-glucans are straight chains with mixed beta-1,3 and beta-1,4 links. Cellulose is also a glucose chain, joined by beta-1,4 links.

Terms and sources
chains of glucose
They build cell walls or store energy. Animals and people do not make them. Stier et al., Nutrition Journal, 2014, a review funded by Leiber, maker of Yestimun; one author worked for Leiber.
Oat and barley beta-glucans
Stier et al., Nutrition Journal, 2014; Zabriskie et al., Nutrients, 2020. Oat and barley beta-glucan is a separate ingredient.
Cellulose
Stier et al., Nutrition Journal, 2014.

Human digestive enzymes cannot split these beta links. Beta-glucans reach the large intestine undigested, where gut bacteria ferment them.

Terms and sources
beta links
Stier et al., Nutrition Journal, 2014.
ferment them
Vlassopoulou et al., Food & Function, 2021.

Immune cells carry a receptor called dectin-1 that recognizes beta-glucan chains with a beta-1,3 backbone. In lab studies, binding needed a backbone of at least 7 glucose units and one beta-1,6 branch. Barley-type chains with mixed links were not recognized.

Terms and sources
dectin-1
Receptors for beta-glucans, including dectin-1, sit on several kinds of white blood cells and on gut lining cells. Stier et al., Nutrition Journal, 2014.
In lab studies
Studies with chains made in the lab, summarized by Stier et al., Nutrition Journal, 2014. Binding grew stronger with longer chains.

In mice, swallowed yeast beta-glucan with a fluorescent label was taken up by macrophages, a type of immune cell. These cells carried it to the spleen, lymph nodes and bone marrow. In the bone marrow, they broke the large chains into smaller pieces that dissolve in water. In 10 healthy men who took 1,000 mg a day for 7 days, beta-glucan was barely detectable in blood. A 2006 study of a soluble yeast beta-glucan found no uptake into blood at 100–400 mg a day.

Terms and sources
macrophages
Hong et al., Journal of Immunology, 2004. Barley beta-glucan was traced the same way.
barely detectable
Levels did not differ from those of 5 men who took nothing (data not shown in the paper). Leentjens et al., PLoS One, 2014.
A 2006 study
18 healthy volunteers, 6 at each amount, for 4 days. Lehne et al., Clinical and Experimental Immunology, 2006.

Where yeast beta-glucan comes from

Yeast cell walls typically hold about 30% beta-glucan by dry weight. For Yestimun, spent brewer's yeast from beer making is broken down by its own enzymes. Centrifuges then separate the soluble yeast extract from the insoluble cell walls. Further steps purify the beta-glucan without strong alkali or acid, which leaves most beta-1,6 branches intact.

Terms and sources
about 30%
Stier et al., Nutrition Journal, 2014. This review was funded by Leiber, the maker of Yestimun.
spent brewer's yeast
Yeast left over after brewing, grown on malt and water. Stier et al., Nutrition Journal, 2014.
beta-1,6 branches
These side chains are sensitive to acid, the review notes.

The same review gives about 22% beta-1,6 links for Yestimun and 10–18% for Wellmune. A product called Glucan #300 has a purity of at least 83%, as its maker states.

Terms and sources
22%
Relative share of beta-1,6 links, measured by nuclear magnetic resonance. Purity: at least 85% of dry matter for Yestimun and at least 75% for Wellmune. Stier et al., Nutrition Journal, 2014, a review funded by Leiber, maker of Yestimun.
Glucan #300
A baker's yeast beta-glucan sold as a supplement, made by Biothera for Transfer Point. Biothera also prepared the Wellmune tested in one trial on this page (Carpenter et al., 2013). Leentjens et al., PLoS One, 2014.

Daily amounts and the upper limit

The trials on this page used 50–1,000 mg of yeast beta-glucan a day, for 7 days to 6 weeks.

Terms and sources
50–1,000 mg
50 mg was the first step of a schedule that rose to 250 mg (McFarlin 2025). Two trials used 250 mg; one used 1,000 mg (Leentjens 2014).

United States

The National Academies have not set an upper limit for yeast beta-glucan. They have not set a recommended amount either. US labels list yeast beta-glucan in mg per serving, without a percent Daily Value.

Terms and sources
upper limit
Yeast beta-glucan has no Dietary Reference Intake. National Academies, Dietary Reference Intakes summary tables.
percent Daily Value
FDA has not set a Daily Value for beta-glucan. 21 CFR 101.36.

In 68 US labels with yeast beta-glucan as the only ingredient, the middle half list 200–500 mg per serving. The most common amounts are 250 mg, 500 mg and 200 mg per serving.

Terms and sources
68 US labels
NIH Dietary Supplement Label Database, including products no longer sold. The only ingredient line is a beta-glucan that names yeast, Saccharomyces cerevisiae or a yeast beta-glucan brand. Brands: Wellmune, WGP, Yestimun, Glucan #300. Nutrition Facts lines were not counted. All 68 state mg. A serving is not always a full day's amount.
250 mg, 500 mg and 200 mg
On 21, 17 and 11 labels. 8 labels list 3 mg; none lists more than 1,000 mg. We counted these.

In the same download, 551 labels list a yeast beta-glucan, and 82% of them list other ingredients too. Another 451 labels list a beta-glucan without naming its source on that line. Brand names on the yeast labels include Wellmune on 67 labels and Yestimun on 3. 199 of the 551 labels name the beta-1,6 link, and 35 list a 70% extract.

Terms and sources
551 labels
Labels with a beta-glucan line that names yeast, Saccharomyces cerevisiae or a yeast beta-glucan brand, including lines inside blends. Glucanase enzymes, chitin-glucan, and oat, barley, mushroom, algae and black yeast glucans are left out. Nutrition Facts lines do not count as other ingredients. We counted these.
451 labels
Lines where the beta-glucan name itself gives no source, such as Beta Glucan or Beta-1,3/1,6-Glucan. In 44 of these labels, the line is a blend listing yeast or another source as a separate item. The package may name the source elsewhere. We counted these.
Wellmune on 67 labels
34 labels name WGP or Whole Glucan Particle; 83 name Wellmune, WGP or both. Named in an ingredient or form line. We counted these.
70% extract
Lines such as Beta 1,3-1,6 Glucans 70% standardized extract. We counted these.

Forms of yeast beta-glucan and how they differ

Yeast beta-glucans in supplements differ by yeast, purification, branching and whether they dissolve in water. A 2014 review, which left out soluble products, found one small human study of soluble yeast beta-glucan. Two trials in marathon runners, published in 2013 and 2020, also tested a soluble baker's yeast beta-glucan. Their main measure was episodes of illness, so they are not shown here. In lab studies, only particles set off the dectin-1 signal inside immune cells. We do not rank forms.

Terms and sources
A 2014 review
Stier et al., Nutrition Journal, 2014. It covered controlled trials found in PubMed. Its Methods say studies with soluble beta-glucans were excluded.
Two trials in marathon runners
McFarlin et al., Journal of Dietary Supplements, 2013: 74 runners took the soluble form. Mah et al., Journal of Medicinal Food, 2020: 76 runners took soluble Wellmune.
only particles
Soluble chains bound to dectin-1 without switching it on; they bound another receptor, CR3. Stier et al., Nutrition Journal, 2014.
Wellmune, Yestimun, Glucan #300, soluble yeast beta-glucan and oat beta-glucan
FormSource and make-upWhat is known
Wellmune (WGP)Baker's yeast; insoluble particles; 10–18% beta-1,6 links; at least 75% purity, as reported by a review funded by Leiber, maker of YestimunTested in two trials on this page: Carpenter 2013 and McFarlin 2025.
YestimunSpent brewer's yeast; insoluble; about 22% beta-1,6 links; at least 85% purity, as reported by a review funded by Leiber, its makerTested in Zabriskie 2020, on this page.
Glucan #300Baker's yeast; insoluble; made by Biothera for Transfer Point; at least 83% purity, as stated by the maker (Leentjens 2014)Tested in Leentjens 2014, on this page.
Soluble yeast beta-glucanDissolves in waterIn lab studies, it did not switch on dectin-1 (Stier 2014). In a 2006 study, none reached the blood (Lehne 2006).
Oat and barley beta-glucanStraight chain with beta-1,3 and beta-1,4 linksA separate ingredient. In lab studies, dectin-1 did not recognize barley-type chains (Stier 2014).

Make-up from Stier 2014, a review funded by Leiber, the maker of Yestimun; Glucan #300 from Leentjens 2014. Trials named are in the studies list below.

Published studies of yeast beta-glucan

4 studies in healthy adults: 2 found a difference, 1 found none, 1 had mixed results.

All 4 measured blood markers, and none measured health outcomes. One also measured soreness, strength and mood. Two tested Wellmune, one Yestimun and one Glucan #300. Not shown: trials whose main measure was episodes of illness, and trials in people selected for a health condition. Also not shown: a vaccine-response trial, a trial without a control group, other reports on the same people, and reviews.

Our one-line summary comes first. The original is on PubMed.

Show the 4 studies
  • Active adults had more blood monocytes after hot-weather cycling with 250 mg of Wellmune than with a dummy capsule.

    Trial · 60 finished; 69 started, by the Methods. · 10 days · maker-funded

    Carpenter et al., The British Journal of Nutrition, 2013

    Terms and sources
    Active adults
    Recreationally active men and women. They took each product for 10 days, one after the other, with a 7-day break.
    blood monocytes
    a type of white blood cell. Pro-inflammatory monocytes were higher right after and 2 hours after cycling; total monocytes at 2 hours. Statistically significant. With the dummy capsule, both fell by 17% from before exercise to 2 hours after; with Wellmune, by 3%.
    hot-weather cycling
    About 49 minutes at 38 °C and 45% humidity.
    250 mg of Wellmune
    Wellmune WGP, beta-1,3/1,6-glucans from baker's yeast, prepared by Biothera.
    a dummy capsule
    placebo: rice flour of similar color and look, in the same kind of capsule
    maker-funded
    Biothera, which prepared the Wellmune used, paid for the study. It coded the bottles and told the researchers the codes after receiving the raw data. The authors declare no conflict of interest.

    Study · Access not checked · about 2 min to read

    Our estimate at about 200 words a minute, from the PubMed abstract. We could not check whether the full text is free.

    Study summary

    Researchers compared Wellmune, a baker's yeast beta-glucan, with rice flour capsules in 60 active men and women. Each took both for 10 days, one after the other, then cycled for about 49 minutes in humid heat. Pro-inflammatory monocytes were higher right after and 2 hours after cycling with beta-glucan, and total monocytes at 2 hours. Lab-stimulated blood cells made more IL-4, IL-5 and interferon-gamma before and right after cycling. Blood IL-4, IL-7, IL-8, IL-10 and interferon-gamma were higher 2 hours later. These differences were statistically significant. The abstract also lists IL-2 and blood IL-5. By the Results, IL-2 differed only before intake, and blood IL-5 did not reach significance. A separate report from the same trial found saliva IgA 32% higher 2 hours after cycling; statistically significant. The trial measured blood markers, not symptoms or health outcomes. 69 adults started and 60 finished. Funding: Biothera, which prepared the Wellmune used.

  • Muscle damage after hot treadmill walking did not differ between Yestimun and a dummy capsule; three blood cytokines did.

    Trial · 35 randomized; 31 finished both periods. · 13 days · maker-funded

    Zabriskie et al., Nutrients, 2020

    Terms and sources
    Muscle damage
    Creatine kinase and myoglobin in blood, and soreness. Muscle strength and white blood cell counts did not differ either.
    hot treadmill walking
    Up to 60 minutes at about 55% of aerobic capacity, at 35–40 °C.
    Yestimun
    250 mg a day of a brewer's yeast beta-glucan. 16 men and 15 women, active but not elite, took each product for 13 days, one after the other. 35 were randomized; 31 of 35 finished.
    a dummy capsule
    placebo: maltodextrin in identical capsules
    three blood cytokines
    6 of 17 cytokines could be measured. From the start to 72 hours after exercise, changes in IL-8, MCP-1 and MIP-1β were lower with Yestimun. Statistically significant. Over the whole time course, only MIP-1β differed between the two.
    maker-funded
    Leiber, which makes Yestimun, paid through an unrestricted grant. The paper says the sponsor had no role in data, analysis or writing.

    Study · Free full text · about 34 min to read

    Our estimate at about 200 words a minute, for the full text on PubMed Central.

    Study summary

    Researchers compared 250 mg a day of Yestimun, a brewer's yeast beta-glucan, with maltodextrin capsules. 35 active adults were randomized and 31 finished; each took both for 13 days, one after the other. Then they walked on a treadmill for up to 60 minutes at 35–40 °C. Muscle damage, soreness, strength and blood cell counts did not differ. Changes in three blood cytokines were lower with Yestimun. Vigor fell only with the dummy capsule, and anger fell more with it. Total mood disturbance rose right after exercise with Yestimun and fell below its starting level by 72 hours. This pattern differed from the dummy capsule. These differences were statistically significant. The trial did not measure health outcomes. Funding: an unrestricted grant from Leiber, which makes Yestimun.

  • In 20 healthy adults, the authors reported 40 of 730 blood mRNAs as different between Wellmune and a dummy pill.

    Trial · 20 enrolled by the Methods, 19 by the abstract; 19 finished. The Methods also say 10 dropped out. · 6 weeks · maker-funded

    McFarlin et al., BioTech, 2025

    Terms and sources
    20 healthy adults
    Aged about 31, with no diagnosed metabolic or inflammatory conditions, tested at rest without exercise.
    40 of 730
    77 of the 730 mRNAs reached statistical significance at one or more time points. The authors kept 40. They removed small changes, results with no treatment effect, and genes without earlier published links to the study topic. They did not use a standard correction for many tests.
    blood mRNAs
    Messenger RNA, the working copies of genes; 730 immune-related genes, measured every 2 weeks. A difference at one or more time points counted. 3 of the 40 (GATA1, RNASE2, IDO1) already differed before intake, by the gene lists in the Results. A later paragraph says 2. For CCL4, CCL5 and IDO1, the Results report increases and the Discussion reports decreases.
    Wellmune
    Baker's yeast beta-glucan. Daily amount: 50 mg in weeks 1–2, 125 mg in weeks 3–4, 250 mg in weeks 5–6.
    a dummy pill
    placebo: maltodextrin. The paper does not say whether participants or staff knew the groups.
    maker-funded
    Kerry, which supplied the Wellmune, paid for the study. The authors declare no conflicts of interest.

    Study · Free full text · about 29 min to read

    Our estimate at about 200 words a minute, for the full text on PubMed Central.

    Study summary

    Researchers compared Wellmune, a baker's yeast beta-glucan, with maltodextrin pills in 20 healthy adults at rest. The daily amount rose from 50 mg to 125 mg and then 250 mg over 6 weeks. Blood was tested every 2 weeks for 730 immune-related mRNAs. 77 mRNAs reached statistical significance. The authors kept 40 after removing small changes and genes without earlier published links to the topic. They did not use a standard correction for many tests. 3 of the 40 already differed before intake. For three genes, the Results and the Discussion give opposite directions. 19 adults finished, and the paper does not describe blinding. The trial measured gene activity in blood, not symptoms or health outcomes. Funding: Kerry, which supplied the Wellmune.

  • Immune-cell responses in lab tests did not differ between men taking 1,000 mg of Glucan #300 and men taking nothing.

    Trial · 15 people · 7 days

    Leentjens et al., PLoS One, 2014

    Terms and sources
    Immune-cell responses
    Cytokines released by blood cells stimulated in the lab, and their killing of yeast cells. Tested before, during and about 2 weeks after intake.
    lab tests
    ex vivo stimulation of white blood cells
    1,000 mg of Glucan #300
    An insoluble baker's yeast beta-glucan sold as a supplement, made by Biothera for Transfer Point. At least 83% purity, as stated by the maker. Once a day for 7 days.
    men taking nothing
    10 healthy men took beta-glucan and 5 took nothing. Everyone knew their group; there was no dummy product.

    Study · Free full text · about 13 min to read

    Our estimate at about 200 words a minute, for the full text on PubMed Central.

    Study summary

    Researchers gave 10 healthy men 1,000 mg a day of Glucan #300, a baker's yeast beta-glucan, for 7 days. Five other men took nothing, and everyone knew their group. Blood cells were stimulated in the lab before, during and after intake. Their cytokine release and their killing of yeast cells did not change with beta-glucan. The differences were not statistically significant. Beta-glucan was barely detectable in blood at any time. The trial measured lab responses of blood cells, not symptoms or health outcomes. Women were not studied. Funding: a grant from the Netherlands Organization for Scientific Research.

Sources

Information, not a prescription. Do not start, stop or combine supplements or medicines on your own.

Find products

Search the catalogue for Yeast Beta-Glucan

Not sure what to choose, or couldn’t find what you were looking for? Ask our expert

Information, not a prescription. Do not start, stop or combine supplements or medicines on your own. If you have a health condition, are pregnant or breastfeeding, take medicines, or are under 18, talk to a doctor or pharmacist first.